Clinical Trial Update: Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating the use of [18]F-FDG PET/CT as a non-invasive method for staging non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Non-small Cell Lung Carcinoma | NA | Status: COMPLETED